Supplementary Materialsoncotarget-10-1440-s001. monotherapy and will potentially function as a biomarker for CRC progression. are frequently associated with a large variety of cancers, such as melanoma [26C29], leukemia [30C32], glioblastoma [33], and lung cancer [25]. Moreover, multiple studies have linked NF1 activity to RAS and ERK activity [28, 29, 33C36], including its role in therapy resistance… Continue reading Supplementary Materialsoncotarget-10-1440-s001. monotherapy and will potentially function as a biomarker for